Coventry’s LILY Funding Program Reaches $1 Billion in Life Insurance-Backed Financing

FORT WASHINGTON, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance and a pioneer of the life insurance-backed asset class, today announced the successful completion of its fourth asset-backed securitization since April 2025 under its LILY program, bringing total life insurance-backed financing across the platform […]

Read More »

Grand Challenges Canada and AVPN Launch Nexa Lighthouse to Fund Climate and Health Innovation Across Asia and the Pacific

— Nexa, the global climate and health innovation initiative, joins forces with The Lighthouse Fund to back locally led solutions to climate-driven health threats across Asia and the Pacific — NEW DELHI, India, Aug. 25, 2026 (GLOBE NEWSWIRE) — Grand Challenges Canada (GCC), AVPN, and global partners today launched Nexa Lighthouse at the AVPN Global Conference 2026, […]

Read More »

Templafy launches free document agent in Microsoft Marketplace

New conversational add-in lets users create, edit and review presentations with AI directly in PowerPoint NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) — Templafy, the agentic document generation platform, today announces the launch of the Templafy Agent Add-In, a free AI agent that enables users to create, edit and review presentations without leaving PowerPoint. Available […]

Read More »

iHerb Marks 30 Years of Making Health and Wellness Accessible with Global Anniversary Sale

Anniversary Event Delivers Deep Savings Across 600+ Brands as iHerb Expands Its Shopping Platform to 46 Languages, Reflecting Surging Global Demand for Health and Wellness IRVINE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) — iHerb, a leading global eCommerce retailer of vitamins, minerals, supplements and other health and wellness products, today announced a global celebration of […]

Read More »

Rampart Withdraws Appeal of USPTO’s Invalidation Decision

ST. PAUL, Minn., Aug. 11, 2026 (GLOBE NEWSWIRE) — Egg Medical announced today that Rampart IC, LLC (“Rampart”) withdrew its appeal of the USPTO’s reexamination decision that the claims of Rampart’s U.S. Patent No. 11, 660,056 as originally granted were invalid. The USPTO’s invalidation is based on grounds that the inventions in the issued ‘056 […]

Read More »